2011 Neopharma receives UAE approval for Gliclazide sustained release tablets. Neopharma makes its foray into CIS Markets with product launches in Tajikistan. Neopharma introduces generic version of anti-diarrheal drug Loperamide in UAE. Neopharma begins marketing of its first injectable product “Advacef”. Neopharma launches generic version of Ivy Leaf extract Syrup. Neopharma receives approval for the launch of generic version of Gliclazide Modified Release Tablets. Neopharma receives approval for the launch of Urinary Alkalinizer, Fluconazole tablets and low osmolarity formula of Oral Rehydration Salts Neopharma further expands operations in the African Market by starting the registration process in Ethiopia and Tanzania. Registration of first set of products completed in Turkmenistan. The UAE Genetic Diseases Association and Neopharma have joined hands for introducing Manal. The launch of Manal will form an integral part of the UAE GDA vision to prevent neural tube defects in the United Arab Emirates by Health Education, Public Awareness and Folic Acid Supplementation targeted for specific population.   2010 Neopharma has received the Certificate of EHS approval from the Abu Dhabi Emirate, Environment, Health and Safety Management System. 2009 Products are introduced into one of the biggest markets in the region – Saudi Arabia Neopharma starts Kuwait operations Neopharma moves into horizontal integration mode.  Ground breaking ceremony heralds the start of new manufacturing facilities. 2008 Neopharma starts operations in the Sultanate of Oman. Neopharma becomes the first pharmaceutical company in the region to obtain the integrated management system encompassing ISO 9001, ISO 14001 & OHSAS 18001. Contract manufacturing for Lagap, Switzerland Neopharma enters the Qatar pharmaceutical market The first exports to East Africa commences with dispatch to Kenya Neopharma enters the Afghanistan markets 2007 Neopharma and Biocon sign a joint venture, heralding the region’s first biotechnology company – Neobiocon.

More updates...